Acorda CTO Batycky is jumping ship to run a biotech; Motif gets a PDUFA date
→ We have one more news item about a biotech exec on the move. Acorda‘s $ACOR chief technology officer Rick Batycky is leaving the company to take the CEO job at an undisclosed private biotech. David Lawrence, Acorda’s chief of business operations, is being charged with the company’s Chelsea, MA manufacturing facility, which produces Inbrija, now under regulatory review as Acorda braces for generic competition to Ampyra.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.